Synergistic enhancement of iron oxide nanoparticle and gadolinium for dual-contrast MRI
- Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health - NIH, Bethesda, MD 20892 (United States)
- Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD 20892 (United States)
Highlights: Black-Right-Pointing-Pointer MR contrast agents exert influence on T{sub 1} or T{sub 2} relaxation time of the surrounding tissue. Black-Right-Pointing-Pointer Combined use of iron oxide and Gd-DTPA can improve the sensitivity/specificity of lesion detection. Black-Right-Pointing-Pointer Dual contrast MRI enhances the delineation of tumor borders and small lesions. Black-Right-Pointing-Pointer The effect of DC-MRI can come from the high paramagnetic susceptibility of Gd{sup 3+}. Black-Right-Pointing-Pointer The effect of DC-MRI can also come from the distinct pharmacokinetic distribution of SPIO and Gd-DTPA. -- Abstract: Purpose: The use of MR contrast agents allows accurate diagnosis by exerting an influence on the longitudinal (T{sub 1}) or transverse (T{sub 2}) relaxation time of the surrounding tissue. In this study, we combined the use of iron oxide (IO) particles and nonspecific extracellular gadolinium chelate (Gd) in order to further improve the sensitivity and specificity of lesion detection. Procedures: With a 7-Tesla scanner, pre-contrasted, IO-enhanced and dual contrast agent enhanced MRIs were performed in phantom, normal animals, and animal models of lymph node tumor metastases and orthotopic brain tumor. For the dual-contrast (DC) MRI, we focused on the evaluation of T{sub 2} weighted DC MRI with IO administered first, then followed by the injection of a bolus of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Results: Based on the C/N ratios and MRI relaxometry, the synergistic effect of coordinated administration of Gd-DTPA and IO was observed and confirmed in phantom, normal liver and tumor models. At 30 min after administration of Feridex, Gd-DTPA further decreased T{sub 2} relaxation in liver immediately after the injection. Additional administration of Gd-DTPA also immediately increased the signal contrast between tumor and brain parenchyma and maximized the C/N ratio to -4.12 {+-} 0.71. Dual contrast MRI also enhanced the delineation of tumor borders and small lesions. Conclusions: DC-MRI will be helpful to improve diagnostic accuracy and decrease the threshold size for lesion detection.
- OSTI ID:
- 22210238
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 425, Issue 4; Other Information: Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
A novel contrast agent with rare earth-doped up-conversion luminescence and Gd-DTPA magnetic resonance properties
Technical Note: Radiological properties of tissue surrogates used in a multimodality deformable pelvic phantom for MR-guided radiotherapy